| Date Filed | Type | Description |
| 05/01/2023 |
4
| Walters-Hoffert Lisa (Director) has filed a Form 4 on Flux Power Holdings, Inc.|
Txns:
| Exercised 17,793 options to buy
@ $0
Exercised 1,526 options to buy
@ $0 |
|
| 04/21/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/08/2023 |
4
| Walters-Hoffert Lisa (Director) has filed a Form 4 on Flux Power Holdings, Inc.|
Txns:
| Bought 1,000 shares
@ $6.3606, valued at
$6.4k
|
|
| 01/26/2023 |
4
| Walters-Hoffert Lisa (CFO) has filed a Form 4 on Dare Bioscience, Inc.|
Txns:
| Granted 290,000 options to buy
@ $1.16, valued at
$336.4k
|
|
| 05/02/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/28/2022 |
4
| Walters-Hoffert Lisa (CFO) has filed a Form 4 on Dare Bioscience, Inc.|
Txns:
| Granted 185,000 options to buy
@ $1.59, valued at
$294.2k
|
|
| 05/03/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/28/2021 |
4
| Walters-Hoffert Lisa (CFO) has filed a Form 4 on Dare Bioscience, Inc.|
Txns:
| Granted 168,000 options to buy
@ $2.59, valued at
$435.1k
|
|
| 03/09/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/03/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/08/2019 |
3
| Walters-Hoffert Lisa (Director) has filed a Form 3 on Flux Power Holdings, Inc. |
| 04/15/2019 |
SC 13D/A
| Walters-Hoffert Lisa reports a 2.8% stake in Daré Bioscience, Inc. |
| 01/31/2019 |
4
| Walters-Hoffert Lisa (CFO) has filed a Form 4 on Dare Bioscience, Inc.|
Txns:
| Granted 75,000 options to buy
@ $0.759, valued at
$56.9k
|
|
| 09/10/2018 |
4
| Walters-Hoffert Lisa (CFO) has filed a Form 4 on Dare Bioscience, Inc.|
Txns:
| Granted 100,000 options to buy
@ $1.01, valued at
$101k
|
|
| 07/28/2017 |
SC 13D
| Form SC 13D - General statement of acquisition of beneficial ownership: |
| 07/21/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/21/2017 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |